Dr. Michio Hirano, MD
Claim this profileColumbia University Irving Medical Center
Affiliated Hospitals
Columbia University Irving Medical Center
Columbia University
Clinical Trials Michio Hirano, MD is currently running
N-Acetylcysteine
for Mitochondrial Disease
N-Acetylcysteine (NAC), an anti-oxidant, will be studied to investigate the effects on brain glutathione levels, cognitive skills, motor skills, and quality of life. A group of 18 participants will take either 1800, 3600 or 5400 mg per day of N-acetylcysteine (NAC) for 3 months in this dose escalation study. The investigators want to determine first if the 3600 mg dose per day is safe and might provide some efficacy. If the 3600 mg dose is safe, then additional participants will be treated with 5400 mg per day of NAC, for up to a total of 18 participants. If the 3600 mg per day dose is unsafe, then participants will be treated with the 1800 mg per day dose. Data from this pilot study will be used to determine the most safe and effective dose of NAC for a future clinical trial.
Recruiting
1 award
Phase 1
3 criteria
Natural History Study
for Mitochondrial Neurogastrointestinal Encephalomyopathy
This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.
Recruiting
1 award
N/A
4 criteria
More about Michio Hirano, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Michio Hirano, MD has experience with
- N-Acetylcysteine
- Deoxycytidine (dCyt)
- Deoxythymidine (dThd)
- IW-6463
- Patient Registry And Biorepository
- None
Breakdown of trials Michio Hirano, MD has run
Mitochondrial Disease
MELAS Syndrome
Hearing Loss
Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michio Hirano, MD specialize in?
Michio Hirano, MD focuses on Mitochondrial Disease and MELAS Syndrome. In particular, much of their work with Mitochondrial Disease has involved m.3243A>G positive patients, or patients who are undergoing treatment.
Is Michio Hirano, MD currently recruiting for clinical trials?
Yes, Michio Hirano, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michio Hirano, MD has studied deeply?
Yes, Michio Hirano, MD has studied treatments such as N-Acetylcysteine, Deoxycytidine (dCyt), Deoxythymidine (dThd).
What is the best way to schedule an appointment with Michio Hirano, MD?
Apply for one of the trials that Michio Hirano, MD is conducting.
What is the office address of Michio Hirano, MD?
The office of Michio Hirano, MD is located at: Columbia University Irving Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Irving Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.